ansa biotechnologies patents：News & Events
News & Events
Ansaistheonlycompanyabletosynthesizecomplete,contiguousDNAoligonucleotidesaslongas600bpwithoutrequiringassembly,deliveringproductsas ...。其他文章還包含有：「AnsaBiotechnologies-Products」、「AnsaBiotechnologiesCloses$68MSeriesAFinancing」、「AnsaBiotechnologiesClosesOversubscribed$68Million...」、「AnsaBiotechnologiesCompanyProfile2024」、「AnsaBiotechnologiessecureslicenseforpolymerase...」...
查看更多 離開網站
Ansa Biotechnologies - Products
https://www.cbinsights.com
Patents. Ansa Biotechnologies has filed 3 patents. The 3 most popular patent topics include: filters; membrane technology; water desalination. patents chart.
Ansa Biotechnologies Closes $68M Series A Financing
https://www.genomeweb.com
The patented method, described in a 2018 Nature Biotechnology paper, deploys polymerase-nucleotide conjugates to rapidly extend a DNA ...
Ansa Biotechnologies Closes Oversubscribed $68 Million ...
https://www.biospace.com
Ansa Biotechnologies today announced it has closed an oversubscribed Series A financing round of $68 million. April 11, 2022 12:00 UTC.
Ansa Biotechnologies Company Profile 2024
https://pitchbook.com
Recent Patent Activity ; Publication ID CA-3240459-A1 ; Patent Title Methods of polynucleotide synthesis ; Status Pending ; First Filing Date 16-Dec-2021.
Ansa Biotechnologies secures license for polymerase ...
https://ansabio.com
The patent covers the core enzymatic DNA synthesis approach that will power Ansa's nucleic acid manufacturing service.
Ansa Biotechnologies ties up $68M for DNA synthesis ...
https://www.fiercebiotech.com
Ansa's patented approach to DNA synthesis was developed by co-founders Daniel Lin-Arlow, Ph.D., and Sebastian Palluk, Ph.D., and described ...
Ansa Biotechnologies, Inc. - Drug pipelines
https://synapse.patsnap.com
Ansa's proprietary enzymatic oligonucleotide synthesis technology is based on its patented Polymerase-nucleotide Conjugate reagents that can rapidly extend a ...
Nucleic acid synthesis and sequencing using tethered ...
https://patents.google.com
This application claims the benefit of U.S. patent application serial no. 62/354,635, filed on June 24, 2016, which application is incorporated by reference ...
US20040198681A1
https://patents.google.com
The present invention relates to protein engineering for production of analogs of MB-1. MB-1 analogs are more stable to different biochemical conditions ...